A B S T R A C T A reproducible microbiologic assay of microgram quantities of idoxuridine (IDU) in serum, urine, or cerebrospinal fluid is presented. The antiviral assay is not interfered with by type-specific antibody or interferon. During slow intravenous infusions of idoxuridine (4 mg/min) in patients with suspected diagnoses of Herpesvirus hominis encephalitis, the rate of inactivation and/or removal of drug exceeded its administration. During several rapid infusions of idoxuridine (50 mg/ min) significant quantities of the drug were found in serum, urine, and cerebrospinal fluid. Idoxuridine is not significantly bound to serum proteins and is not deiodinated in fresh serum or urine in vitro to inactive products (iodouracil, uracil, iodide). It is rapidly excreted into the urine. Inactivation of IDU occurs in tissues. This antiviral assay of IDU in body fluids should be applicable to other viruses and potential antiviral agents.
INTRODUCTION
The effective use of an antibacterial agent versus bacterial infection requires information relating to its in vitro effectiveness and pharmacologic properties in vivo. Particularly, the latter information, when coupled with careful clinical observation, allows assessment of the toxic to therapeutic concentrations. In turn, limits of usefulness of the substance in question are defined.
In vitro methods of assay of antiviral activity have been reported (1) . After administration of potentially useful antiviral drugs to man, quantitative measures of activity in body fluids, to our knowledge, have not been reported. Antiviral properties in specimens from patients attributable to drugs must be clearly separated from similar activities of interferon or type-specific antibody.
We report: (a) a quantitative microbiologic assay for 5-iodo-2'-deoxyuridine (idoxuridine, IDU') in body fluids; (b) data relating to the stability of IDU in serum, urine, and cerebrospinal fluid; (c) minimal inhibitory concentrations (MIC) of (2) (3) (4) (5) (6) (7) (8) . METHODS 
Cells. A single vial of baby hamster kidney cells (BHK-
) was obtained from the American Type Culture Collection. 2 Cells were maintained in our laboratory, and used throughout. Tissue cultures were grown in 32-ounce monolayer bottles with Eagle's medium (EM) -in Earle's solution (BSS) and twice normal concentrations of amino acids supplemented with 10% tryptose phosphate broth, 10% calf serum, 0.005% phenol red, and 50 ,ug/ml of penicillin and streptomycin. For virus or antiviral assays, cells were grown in screw-capped test tubes or 30-ml plastic tissue culture flasks, respectively. Test tubes were seeded with 1 ml, tissue culture flasks with 4 ml of growth medium containing 1.2 x 10' cells/ml. Overlay medium for plaque assay contained equal volumes of twice-concentrated medium 199 in BSS and 10% fetal calf serum with 0.6% 'Abbreviations used in this paper: BHK, baby hamster kidney cells; BSS, Earle's solution; CSF, cerebrospinal fluid; EM, Eagle's medium; IDU, idoxuridine; MIC, minimal inhibitory concentration; pfu, plaque-forming units. Adsorption of herpesvirus is unaffected in BSS, fresh serum, or 6 g/100 ml albumin in BSS (Table I) . Idoxuridine is stable after incubations in serum at 36°C for from 1 through 168 hr. In vivo, IDU is metabolized to iodouracil, uracil, and iodide-products which have no antiherpesvirus activity (15, 16 amounts of IDU in urine, cerebrospinal fluid, or sera confirm original determinations. Idoxuridine, therefore, is also not deiodinated in urine. In this assay, addition of specimens after adsorption of virus eliminates antiviral activity of neutralizing antibody. Likewise, use of baby hamster kidney cells utilizes species' specificity of human interferons, and eliminates antiviral activity of these natural intracellular inhibitors of virus (17) .
For determination of concentration of IDU (serum, urine, CSF) and MIC's of recently isolated herpesvirus strains, end points were read as that dilution producing a 50% reduction in plaque-forming units. In these assays 50-150 plaque-forming units were used as the herpesvirus challenge.
Intravenous administration of idoxuridine. Patients 
RESULTS
Repetitive determinations of 0.67-20 Ag of IDU per 0.4 ml in antiviral assays give almost identical numbers of pfu of Ket virus. Data from five such standard curves are shown in Fig. 1 . During infusions of idoxuridine 22 samples of serum, 11 urines, and 6 cerebrospinal fluids were tested for antiviral activities (Table II) . Six sera, six urines, and one cerebrospinal fluid contained measurable idoxuridine. Values in sera ranged from 9 to 36 *g/ml; urines 45 to 1,040 Ag/ml; and the single CSF with activity had 833 ug/ml. No specimen of serum, urine, or cerebrospinal fluid collected after cessation of IDU contained antiviral activity. The data are striking in that most specimens obtained during slow infusions of idox- uridine contain no measurable activity. They confirm previous pharmacologic experiments using 13 .I labeled 5-iodo-2'-deoxyuridine indicating that rapid, and here, almost instantaneous transfer of idoxuridine into tissues and urine occurs (15, 16 (6) , (d) difference of the density and base composition of their deoxyribonucleic acid (8) , and (e) antigenic distinctiveness of herpesvirus genital strains.
The actual concentration of active compound which is present after optimal administrations in the brain and other organs is critical information which remains to be determined. The data presented do not show that idoxuridine is effective therapy of herpesvirus infections, but they do offer basic pharmacologic information which need to be considered in possible formulations concerning treatment. Such a formulation for a 70 kg man might be 2.4 g of idoxuridine in 250 cc of 5% glucose in water as an intravenous infusion given over a 60 min period every 12 hr for 4 (or possibly 5) consecutive days. The final day of therapy would be dependent upon the findings at a bone marrow examination obtained on the morning of the 5th day. It has been our experience that infants and children sustain larger total dosages with lesser signs of toxicity.
